https://inthought.com/wp-content/uploads/2019/03/inThought-Logo-Transparent-3.7.png 0 0 clickgiant https://inthought.com/wp-content/uploads/2019/03/inThought-Logo-Transparent-3.7.png clickgiant2021-01-19 21:01:052021-01-19 21:01:05TOXINS 2021: Ipsen to Present New Analysis of Phase 3 Data Demonstrating the long-duration of Dysport in Five Therapeutic Indications
January 15, 2021
- Ipsen will present 26 abstracts at TOXINS 2021.
- A key presentation titled AbobotulinumtoxinA: Evidence for Long Duration of Response from 5 Patient Populations demonstrates long-duration of Dysport.
- Data from the long-term open-label extension study indicated that repeat cycles of Dysport resulted in at least 12 weeks duration for a large proportion of study patients for the management of cervical dystonia (CD), adult lower-limb (ALL) and upper-limb (AUL) spasticity, and upper-limb (PUL) spasticity. Data for pediatric upper limb spasticity indicated duration of at least 16 weeks.
- The results from the phase 3 new analysis are confirmed with real-world data from the ULIS-III observational study.
Source: Ipsen Press Release